Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.62 |
| ▸ | MAPT | P10636 | 4/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | BLM | P54132 | 2/20 | 0.62 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.62 |
| ▸ | MPO | P05164 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | HTR2A | P28223 | 2/20 | 0.51 |
| ▸ | HTR2C | P28335 | 2/20 | 0.51 |
| ▸ | HTR2B | P41595 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | HTR1A | P08908 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29556951 | 1.00 | KMT2A (0.62) | KMT2AKDM4EMAPTMEN1LMNA | |
| SCHEMBL109838 | 1.00 | KMT2A (0.62) | KMT2AKDM4EMAPTMEN1LMNA | |
| SCHEMBL29406297 | 1.00 | KMT2A (0.62) | KMT2AKDM4EMAPTMEN1LMNA | |
| SCHEMBL21055747 | 1.00 | KMT2A (0.62) | KMT2AKDM4EMAPTMEN1LMNA | |
| SCHEMBL18028997 | 1.00 | KMT2A (0.62) | KMT2AKDM4EMAPTMEN1LMNA | |
| SCHEMBL24113154 | 0.89 | GPR84 (0.56) | KMT2AKDM4EMAPTMEN1LMNA | |
| SCHEMBL30310459 | 0.89 | GPR84 (0.56) | KMT2AKDM4EMAPTMEN1LMNA | |
| SCHEMBL16975866 | 0.89 | GPR84 (0.56) | KMT2AKDM4EMAPTMEN1LMNA | |
| SCHEMBL29415609 | 0.86 | KMT2A (0.62) | KMT2AKDM4EMAPTMEN1LMNA | |
| SCHEMBL24113156 | 0.85 | GPR84 (0.52) | KMT2AKDM4EMAPTMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1383 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600699-B2 | Thiosemicarbazates and uses thereof | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-04-14 | — | — | US | claimed |
| US-12428447-B2 | Peptide-based non-proteinaceous cargo delivery | FELDAN BIO INC. (CA) | 2025-09-30 | — | — | US | claimed |
| US-12351573-B2 | Compounds for use in synthesis of peptidomimetics | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2025-07-08 | — | — | US | claimed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| US-20240197896-A1 | SYNTHETIC PEPTIDE SHUTTLE AGENT BIOCONJUGATES FOR INTRACELLULAR CARGO DELIVERY | FELDAN BIO INC. (CA) | 2024-06-20 | — | — | US | claimed |
| CN-117750978-A | Synthetic peptide shuttle bioconjugates for intracellular cargo delivery | 费尔丹生物公司 | 2024-03-22 | — | — | CN | claimed |
| EP-4313159-A1 | SYNTHETIC PEPTIDE SHUTTLE AGENT BIOCONJUGATES FOR INTRACELLULAR CARGO DELIVERY | Feldan Bio Inc. (CA) | 2024-02-07 | — | — | EP | claimed |
| US-20230399661-A1 | SHUTTLE AGENT PEPTIDES OF MINIMAL LENGTH AND VARIANTS THEREOF ADAPTED FOR TRANSDUCTION OF CAS9-RNP AND OTHER NUCLEOPROTEIN CARGOS | FELDAN BIO INC. (CA) | 2023-12-14 | — | — | US | claimed |
| US-20230383291-A1 | PEPTIDE-BASED TRANSDUCTION OF NON-ANIONIC POLYNUCLEOTIDE ANALOGS FOR GENE EXPRESSION MODULATION | FELDAN BIO INC. (CA) | 2023-11-30 | — | — | US | claimed |
| US-11752131-B2 | Methods and pharmaceutical compositions for the treatment of obesity | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2023-09-12 | — | — | US | claimed |
| EP-0809703-A1 | METHODS FOR MAINTAINING STERILITY IN PLANTS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 1997-12-03 | — | — | EP | claimed |
| WO-1996025505-A1 | METHODS FOR MAINTAINING STERILITY IN PLANTS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 1996-08-22 | — | — | WO | claimed |
| WO-1993006220-A1 | TRYPTOPHAN ANALOGUES AS SELECTIVE AGENTS IN THE TRANSFORMATION OF PLANTS AND PLANT CELLS | MOGEN INTERNATIONAL N.V. (NL) | 1993-04-01 | — | — | WO | claimed |
| EP-0183006-B1 | A RECOMBINANT DNA-MOLECULE, CORYNEFORM BACTERIA CARRYING RECOMBINANT DNA AND PROCESS FOR PRODUCING AN AROMATIC AMINO ACID BY USING THE SAME | AJINOMOTO CO., INC. (JP) | 1992-02-26 | — | — | EP | claimed |
| US-5034318-A | Culturing Coryneform glutamic acid producing bacteria with plasmids | AJINOMOTO CO., INC. (JP) | 1991-07-23 | — | — | US | claimed |
| US-5017481-A | Biosynthesis | AJINOMOTO CO., INC. (JP) | 1991-05-21 | — | — | US | claimed |
| EP-0183006-A2 | A recombinant DNA-molecule, coryneform bacteria carrying recombinant DNA and process for producing an aromatic amino acid by using the same | AJINOMOTO CO., INC. (JP) | 1986-06-04 | — | — | EP | claimed |
| EP-0136359-A1 | PROCESS FOR PREPARING L-HISTIDINE | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) | 1985-04-10 | — | — | EP | claimed |
| US-4371614-A | E.Coli bacteria carrying recombinant plasmids and their use in the fermentative production of L-tryptophan | AJINOMOTO CO., INC. (JP) | 1983-02-01 | — | — | US | claimed |
| US-3930948-A | ENZYMATIC METHOD FOR PRODUCING AROMATIC ETHYLAMINES | AJINOMOTO CO., INC. (JA) | 1976-01-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12351573-B2 | Compounds for use in synthesis of peptidomimetics | DNPEP, NPEPPS, PAM | KMT2A 1848/4885KDM4E 3819/4885MAPT 1350/4885 |
| US-20240197896-A1 | SYNTHETIC PEPTIDE SHUTTLE AGENT BIOCONJUGATES FOR INTRACELLULAR CARGO DELIVERY | SCAMP2, SLC7A1, NUMA1 | KMT2A 4507/4885KDM4E 4852/4885MAPT 2658/4885 |
| US-11752131-B2 | Methods and pharmaceutical compositions for the treatment of obesity | IDO1, IDO2, GPR119 | KMT2A 1002/4885KDM4E 640/4885MAPT 2886/4885 |
| US-12600699-B2 | Thiosemicarbazates and uses thereof | MET, THRB, ABAT | KMT2A 2188/4885KDM4E 2649/4885MAPT 1679/4885 |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | KMT2A 3415/4885KDM4E 3586/4885MAPT 1809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.